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There are two main reasons why sperm may be absent from semen. Obstructive azoospermia is the result of a
blockage in the male reproductive tract; in this case, sperm are produced in the testicle but are trapped in the
epididymis. Non-obstructive azoospermia is the result of severely impaired or non-existent sperm production.
There are three different sperm-harvesting procedures that obstructive azoospermic males can undergo,
namely MESA (microsurgical epididymal sperm aspiration), PESA (percutaneous epididymal sperm aspiration),
and TESA (testicular sperm aspiration). These three procedures are performed by fine-gauge needle aspiration
of epididymal fluid that is examined by an embryologist. Additionally, one technique, called TESE (testicular
sperm extraction), is offered for males with non-obstructive azoospermia. In this procedure, a urologist extracts
a piece of tissue from the testis. Then, an embryologist minces the tissue and uses a microscope to locate sperm.
Finding sperm in the testicular tissue can be a laborious 2- to 3-hour process depending on the degree of sperm
production and the etiology of testicular failure. Sperm are freed from within the seminiferous tubules and
then dissected from the surrounding testicular tissue. It is specifically these situations that require advanced
reproductive techniques, such as ICSI, to establish a pregnancy. This review describes eight different lab
processing techniques that an embryologist can use to harvest sperm. Additionally, sperm cryopreservation,
which allows patients to undergo multiple ICSI cycles without the need for additional surgeries, will also be
discussed.
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& INTRODUCTION
Azoospermia is defined as an absence of spermatozoa in
the ejaculate (1), and it is classified as either obstructive or
non-obstructive. Obstructive azoospermia is the result of a
blockage in the male reproductive tract; therefore, sperm
production in the testicle is normal, but the sperm are
trapped inside the epididymis. The absence of sperm in the
ejaculate can be due to an abnormality in the epididymis,
vas deferens, or ejaculatory ducts. The obstruction can be
caused by many factors, such as infection, surgery (vasec-
tomies), or an absent vas deferens. Non-obstructive azoos-
permia is the result of severely impaired or non-existent
sperm production. Approximately 10% of male factor
infertility has been attributed to complete azoospermia,
which presents either in an obstructive or a non-obstructive
form (2).
There are four different harvesting techniques that can be
used to obtain sperm for in vitro fertilization (IVF). Each
procedure has advantages and disadvantages and is
described below. Sperm-harvesting techniques used to
obtain sperm from men with obstructive azoospermia are
described in the following paragraphs.
MESA (microsurgical epididymal sperm aspiration):
Using an intraoperative stereomicroscope, a cut is made in
a single tubule of the epididymis. The contents therein,
which should contain sperm, are then aspirated with a fine-
gauge needle. An embryologist examines the sample for the
presence of motile sperm. If no motile spermatozoa are
found at the first site, the maneuver is repeated. Typically,
only a few microliters of epididymal fluid are retrieved
because sperm are highly concentrated in the epididymal
fluid (approximately 16106 sperm/ml). A MESA approach
should provide more than adequate numbers of sperm for
immediate use, as well as for cryopreservation. As reported
by Dr. Shlegel and colleagues, who used MESA and ICSI in
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a group of men with obstructive azoospermia, clinical
pregnancies were detected by a fetal heartbeat in 75% (57/
76) of attempts, and healthy deliveries occurred in 64% (49/
76) of attempts (3).
PESA (percutaneous epididymal sperm aspiration): This
simple technique can be performed under local anesthesia
or mild sedation. Unlike MESA, where the surgeon is able to
visualize the exposed epididymal tubules, PESA is a blind
procedure. A fine needle is used to puncture the epididy-
mis, and sperm are aspirated and given to an embryologist
to examine. Again, if no motile spermatozoa are found at the
first site, the surgeon will repeatedly draw samples for an
embryologist to examine.
TESA (testicular sperm aspiration): For obstructive
azoospermia patients in whom sperm cannot be found in
the epididymis, it is always possible to find sperm in the
testis. TESA may be performed as a primary harvesting
technique if there is an absent epididymis or severe
epididymal fibrosis. This blind procedure is usually
performed under local anesthesia or mild sedation. A
wide-bore needle is pushed into the testis through the skin,
suction is applied, and the contents of the needle are flushed
into a petri dish containing culture media. Then, an
embryologist examines the aspirate for motile or immotile
spermatozoa with a stereomicroscope. Using fine needles,
sperm are released from within the seminiferous tubules,
where sperm are produced, and they are then dissected
from the surrounding tissue. Next, the embryologist
determines whether there is a sufficient number of sperm
for treatment or cryopreservation for future use. If not,
several more needle biopsies will be attempted by the
surgeon in each testis to obtain a sufficient amount.
TESE (testicular sperm extraction): This technique is
reserved for men with non-obstructive azoospermia. This
procedure is also routinely carried out under mild sedation
or local anesthesia. The surgeon exposes a small area of the
testis by making an incision in the scrotum. The seminifer-
ous tubules are forced out through the incision by gently
squeezing the testis, the tubules are excised and the biopsy
sample is placed in a petri dish and given to an
embryologist to examine. An approximately 500-g biopsy
sample is rinsed in culture media to remove red blood cells
and divided into small pieces, using fine needles, under a
stereomicroscope to check for sperm (4). If no sperm are
found, the surgeon will continue taking biopsies from
different areas of the testis, and the embryologist will
continue to examine the samples.
Sperm can usually be easily obtained from infertile men
with obstructive azoospermia for intracytoplasmic injection
(ICSI); however, individuals who exhibit non-obstructive
azoospermia have historically been difficult to treat (4).
Examining biopsies for sperm under a microscope can be
very time-consuming and difficult. Finding sperm in the
testicular tissue can be a laborious 2- to 3-hour process
depending on the degree of sperm production and the
etiology of testicular failure, especially in men with partial
testicular failure. For men with non-obstructive azoosper-
mia, some IVF clinics ask that a TESE be performed a day
before the egg retrieval process because they believe
culturing the testicular tissue in an incubator overnight will
help sperm to acquire motility. When sperm are not found
after surgery, the couple must decide whether they want to
cancel the egg retrieval, cancel the fertility cycle, or proceed
with donor sperm. Alternatively, oocyte collection can be
performed even if no sperm are found in the TESE process
and there is no donor sperm back-up. In this case, eggs can
be cryopreserved to enable the couple to make future
fertility decisions. Importantly, this new option is available
because vitrification has significantly improved oocyte
survival rates. For men who must undergo sperm-harvest-
ing procedures to recover testicular or epididymal sperm, it
is now possible to cryopreserve the excess sperm for future
cycles if needed, thus eliminating the need for repeat
surgery. However, some clinics still prefer to use freshly
retrieved epididymal or testicular sperm instead of frozen-
thawed samples.
& INTRACYTOPLASMIC SPERM INJECTION (ICSI)
Two major breakthroughs have recently occurred in the
area of male infertility (4). The first is the development of
the intracytoplasmic sperm injection (ICSI) technique for the
treatment of male factor infertility due to severely abnormal
semen quality. The second is the extension of ICSI to
azoospermic males and the demonstration that spermatozoa
derived from either the epididymis or the testis are capable
of producing normal fertilization and pregnancy (4). ICSI is
now the primary technique used to treat male-factor
infertility. ICSI has achieved consistent fertilization and
high pregnancy rates in couples with suboptimal sperma-
tozoa (5). Although the fertilization rates obtained with
surgically retrieved spermatozoa were satisfactory, they
were significantly lower than those achieved with fresh
ejaculates (6). A concern associated with the use of
suboptimal spermatozoa for ICSI is the potential for
transmitting the genetic abnormalities responsible for male
infertility to the offspring (4). Despite this concern, ICSI is
the customary therapeutic approach, although genetic
screening and patient counseling are still imperative for
these patients.
In IVF clinics, surgically retrieved sperm samples are
most often prepared for use before a patient progresses
through an ICSI cycle. This is a safe course of action in cases
of obstructive azoospermia, but in cases of non-obstructive
azoospermia, it is beneficial to undergo the surgery before
the cycle because the female has already been stimulated
with medication. At that time, a couple would have to
decide whether to proceed with donor sperm or cryopre-
serve the oocytes for use at a later time. Epididymal
aspirates are relatively easy to prepare in the lab, either
for ICSI or for cryopreservation. Typically, an embryologist
washes the sample with culture media to dilute any
epididymal fluid or blood contamination. The most com-
mon issues are a high level of red blood cells, an absence of
observed sperm, poor sperm motility, and slow progression
(5).
& DIFFERENT METHODS FOR PROCESSING
EPIDIDYMAL AND TESTICULAR SPERM SAMPLES
Shredding method
The preparation of testicular samples is more difficult if
the sperm are contained within the seminiferous tubules.
Many of the sperm found are immature, with a large
cytoplasmic drop attached to the head, and some sperm are
motile; however, most are still viable for ICSI. It is
advantageous to perform the sperm retrieval procedure at
least 24 hours in advance of the egg retrieval process, as
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motility improves with time in culture (7). Biopsies will
always require incubation before motility is observed. In
some cases, it was found that the sample needed to be
cultured for at least 24 hours at 37 C˚.
A common procedure associated with the shredding
method is the excision of testicular tissue by a surgeon and
its subsequent examination by an embryologist. The tissue
can be finely minced and teased apart with fine needles or
glass slides in HEPES-buffered media. Then, the product is
placed in a 5-ml Falcon tube and centrifuged for 5 minutes
at 1,800 g. The supernatant is removed with a Pasteur
pipette, and the pellet is resuspended in 0.2 ml of culture
media. The number of spermatozoa in the droplet can be
very low, as well as poor motility when visualized micro-
scopically. An embryologist must retrieve sperm from the
field of debris, red blood cells, and Sertoli cells for ICSI.
Then, the sperm suspension can be incubated at 37 C˚ until
the time of ICSI (8).
Squeezing method
Seminiferous tubules are teased apart and rinsed to remove
blood contamination, and they are then placed into a petri dish
with fresh culture media. Tubules are then cut into short
lengths (1-2 cm) with fine needles. A long, thin Pasteur pipette
is pulled over a flame and then bent (ideally at an angle of 45 )˚.
A second pipette (without a bend) should be heated and used
to pick up the tubule contents. By holding one end of a cut
tubule with the point of a needle, the bent pipette can be run
along the length of the tubule while simultaneously pushing
down against the base of the petri dish. This procedure
squeezes the entire contents of the tubule into the medium.
The contents can now be picked up with the second pulled
pipette and placed in a test tube filled with clean spermmedia
or placed on a slide to look for sperm (9).
Cell strainer
A method for processing large biopsy samples that has
the benefit of removing unwanted debris consists of the use
of a cell strainer. First, the biopsy sample is teased apart and
sliced with fine needles. These slices are rinsed in a series of
petri dishes containing sperm preparation media to remove
any blood contamination. The tubules are then placed in a
cell strainer (Becton Dickinson & Company, Franklin Lakes,
New Jersey, USA). Heat-treating the end of a clean, sterile
Pasteur pipette produces a sphere-shaped tip approximately
5 mm in diameter. This pipette is used as a pestle to grind
and break up the seminiferous tubules against a mesh
strainer (9).
Tissue grinder method
Another method for processing large tissue samples is to
use a mini-tissue grinder. The tissue is teased apart, sliced
with fine needles and placed in a test tube with fresh culture
media and a glass pestle. With the glass pestle, the sample is
ground at the bottom of a glass tube. Then, the sample is
concentrated via centrifugation. After centrifugation, the
pellet is resuspended with fresh culture media and placed
on a Petri dish in 10-ml drops to look for sperm.
Erythrocyte lysing buffer method
Sperm recovery from epididymal fluid is usually rapid
and efficient, whereas the recovery of sperm cells from
testicular biopsy specimens is more difficult, especially in
cases of non-obstructive azoospermia. The main difficulty is
due to the abundance of red blood cells in shredded
testicular biopsy specimens. The presence of a very high
concentration of erythrocytes and the very infrequent
occurrence of sperm cells sometimes result in a much
longer examination (10). Therefore, one option for testicular
biopsy specimens is suspension in Hepes-buffered medium.
This can then be centrifuged for 5 minutes at 300 g.
Treatment of the testicular sperm pellet with erythrocyte
lysing buffer is performed by resuspending the testicular
sperm pellet in 2 to 4 ml of erythrocyte lysing buffer
(155 mM NH4Cl, 10 mM KHCO3, and 2 mM ethylenedia-
minetetracetic acid; pH 7.2) for 10 minutes at room
temperature. Then, 5 to 10 ml of Hepes-buffered medium
supplemented with protein is added to the suspension in
the same tube and then centrifuged for 10 minutes at 500 g.
The pellet is then resuspended with 1.5 ml of culture media
with protein. This resuspended pellet can be transferred to
an Eppendorf tube and centrifuged again at 500 g for 5
minutes. After centrifugation, the pellet is resuspended in
50 ml of culture media supplemented with protein. This
pellet is then placed in an injection dish that contains 20-30
droplets containing 5 ml of Hepes-buffered medium; the
central droplet is composed of 10% PVP solution.
Subsequently, the embryologist can search for spermatozoa
in the sample that will be used for ICSI. This method is
beneficial when there is a large amount of red blood cell
contamination in the sample. This technique has been
reported and described in more detail by Nagy and
colleagues (10). One of the main difficulties in finding
spermatozoa in a testicular sample is the abundance of
erythrocytes (10).
The hypoosmotic swelling test (HOS test)
The hypoosmotic swelling test (HOS) was developed by
Jeyandran et al. (1984) (11) to evaluate the functional
integrity of the sperm membrane. Viable sperm with normal
membrane function will exhibit tail swelling and curving
due to the influx of water when exposed to hypoosmotic
conditions. The use of this test for distinguishing viable
from non-viable spermatozoa for ICSI was first proposed by
Desmet et al. in 1994 (12). It has been shown that the
fertilization rate after ICSI of randomly selected, immotile
spermatozoa is usually very low, especially with ejaculated
spermatozoa (13,14). There is a reduced success rate of
fertilization for azoospermic males due to the injection of
non-viable spermatozoa, which cannot be distinguished
from viable spermatozoa with no motility. Application of
the hypo-osmotic swelling test, however, seems to be a
promising method of identifying live spermatozoa for ICSI
(14). Casper et al. (1996) (15) conducted a study that showed
a higher fertilization rate after injecting spermatozoa
selected by the HOS test than after injecting randomly
selected spermatozoa.
Another study using the HOS test has also been reported.
In that study, immotile spermatozoa were suspended in a
microdroplet consisting of 50% culture medium and 50%
Millipore-grade water. After a maximum of 10 seconds, the
viable spermatozoa, whose tails were curved and swollen,
were selected and transferred to another microdroplet of
Hepes-buffered medium where they were washed three
times to osmotically re-equilibrate them before transferring
them to a PVP drop. The group found that the modified
HOS test resulted in improved fertilization and pregnancy
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rates compared with the regular HOS test and non-use of
the HOS test (16).
Pentoxyfylline method
Pentoxyfylline is a phosphodiesterase inhibitor of the
methylxantine group. It inhibits the breakdown of cyclic
adenosine monophosphate (cAMP), a molecule known to
play a role in sperm motility (17). It was found that adding
pentoxyfylline to a testicular sperm sample caused sperm
to be motile. This procedure is performed by adding
pentoxyfylline to the sperm suspension at a 1:1 ratio so
that the final concentration of pentoxyfylline in the sample
is 0.5 mg/ml. The sample is incubated at 37 C˚ for 20
minutes. Next, the sample is observed for the identification
and isolation of motile sperm. Some studies have shown
that pentoxyfylline is toxic and should not be used (18). It
has been suggested that a lower concentration of pentox-
yfylline with shorter exposure times may be beneficial (17).
One study found that this was a better and quicker
identification and selection method for vital sperm for use
with ICSI. This procedure also resulted in better fertiliza-
tion rates and less time consuming for staff involved in
TESA/TESE (17).
Collagenase method
In a study by Crabbe et al. in 1997 (19), the enzymatic
treatment of testicular biopsies with collagenase type IV was
applied in clinical ICSI cases where no spermatozoa had
been found after the sample was minced using two fine
needles. This procedure was performed to determine
whether spermatozoa can be recovered from the residual
tissue pieces. This method is performed by shredding the
testicular biopsy sample with fine needles. Microscopic
examination of the wet preparation is carried out at 400x
magnification under an inverted microscope. Biopsy fac-
tions are further minced with two fine forceps in the Petri
dish until tissue pieces of ,1 mm3 or free tubule pieces of a
few millimeters in length are obtained (19). Spermatozoa are
directly recovered from the pellet after centrifuging the
supernatant of the shredded tissue at 300 g for 5 minutes.
Then, erythrocyte-lysing buffer is used to increase the
probability of visualizing any spermatozoa or elongated
spermatids (19). The residual pieces are placed in 1 ml of
pre-warmed HEPES medium supplemented with protein,
1.6 mM CACL2, 25 mL/ml DNase, and 1000 IU/ml collage-
nase Type IV. The tissue samples are then placed in an
incubator at 37 C˚ for 1 hour to allow digestion to occur. To
facilitate complete enzymatic digestion, the samples are
shaken every 10-15 minutes during the incubation period.
The digested tissue solution is gently centrifuged for 5
minutes at 50 g to remove any residual pieces or debris not
dissolved by the enzymes. The remaining cell suspension
(supernatant) containing loose cells is then washed twice
with culture media and centrifuged for 5 minutes at 1000 g.
The supernatant is removed, and the pellet is resuspended
once more with 50-100 ml. A 5-ml drop of the suspension is
examined on a glass slide with a coverslip and placed under
an upright phase contrast microscope. When spermatozoa
are found in one of the suspensions, multiple small droplets
are added under oil in a Petri dish to further examine and
retrieve spermatozoa for ICSI.
This study concluded that the fertilization rate obtained
using the samples treated with collagenase type IV was
comparable to that obtained using the samples retrieved via
the shredding method. This method can be considered
successful in reducing sperm recovery failure and may
increase the chance of selecting the highest quality
spermatozoa in patients with non-obstructive azoospermia
(19).
& CRYOPRESERVATION OF TESTICULAR AND
EPIDIDYMAL SAMPLES
Successful sperm cryopreservation allows patients to
have multiple ICSI cycles without the need for additional
sperm harvesting procedures. Because ICSI enables severely
impaired viable sperm to fertilize an oocyte, cryopreserved
sperm can achieve rates of fertilization and pregnancy
similar to those achieved using fresh sperm (4). Studies have
also found that the cryopreservation of testicular sperm is
more problematic than the cryopreservation of epididymal
sperm because testicular tissue yields a much lower number
of spermatozoa with limited motility. Nevertheless, reports
have indicated that it is possible to cryopreserve testicular
biopsy tissue samples and subsequently extract spermato-
zoa after thawing, with at least isolated pregnancies being
achieved (8).
Although the use of cryopreserved testicular sperm for
ICSI has several advantages, the data concerning the
outcomes of IVF-ICSI procedures using frozen-thawed
testicular sperm are still controversial. Some investigators
claim that they have demonstrated, in obstructive and non-
obstructive azoospermic men, that cryopreserved sperm can
function as well as fresh sperm (20). Additionally, some labs
have shown that the use of frozen-thawed testicular sperm
for ICSI results in higher abortion rates and lower live birth
rates compared with fresh testicular sperm (20).
Without cryopreservation, testicular tissue and testicular
sperm can only be used for one ICSI cycle. Lacking
cryopreserved sperm, each cycle of ICSI in these couples
requires repeated surgeries. Repeated testicular surgeries
can cause permanent testicular damage, irreversible atro-
phy, deterioration of spermatogenic development, and even
loss of endocrine function (2). The cryopreservation of
samples allows for multiple ICSI cycles and minimizes the
number of invasive testicular surgeries.
Surgically recovered sperm from PESA can be cryopre-
served in a manner similar to the cryopreservation of fresh
ejaculates, although the post-thaw survival rates are usually
very poor. Due to extreme variability in post-thaw survival
rates, it is important to freeze a small aliquot for a post-thaw
survival test. This test requires thawing of the sample the
day before the egg retrieval. In cases of virtually zero post-
thaw survival, having results from the test sample allows
time for the patient to consider what precautions to take if
no viable sperm are identified on the day of their partner’s
egg retrieval. Because there is never an absolute guarantee
that cryopreserved sperm will thaw with appropriate
viability, counseling patients regarding the use of donor
sperm as a back-up should be considered, as well as options
of repeat surgery or oocyte cryopreservation.
Haberman described the following cryopreservation
technique (20). The biopsy specimen is placed in a petri
dish with HEPES buffer supplemented with protein at 37 C˚.
Under a dissecting microscope, the seminiferous tubules are
teased apart using fine needles, and the contents are
squeezed into the surrounding media. The tubules are
transferred to a 15-ml conical tube containing 1 ml of fresh
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media. The cell suspension is then transferred to a separate
centrifuge tube. Both tubes are incubated at 37 C˚ for 15-30
minutes, and the supernatant (containing tubules) is
combined within the cell suspension in the second tube.
The suspension is centrifuged at 500 g for 5 minutes, and the
pellet is resuspended in 1 ml of fresh media with protein. A
cell count is performed, and the suspension is diluted or
concentrated to 0.5-1.0 million sperm/ml. Before freezing,
an aliquot is removed to assess sperm quality. At the time of
cryopreservation, multiple aliquots of sperm are frozen
whenever possible along with a test cryovial. The cell
suspension is slowly mixed in a 1:1 ratio with test yolk
buffer and 12% glycerol so that the final concentration of
glycerol is 6%. The samples are slowly cooled at a rate of -
0.5 C˚/min to 4 C˚ and then packaged in 1-ml cryovials. The
vials are frozen at a rate of -10 C˚/min to -90 C˚ and are
stored in liquid nitrogen at -196 C˚ (20). A study was
conducted using this protocol for 29 patients with obstruc-
tive and non-obstructive azoospermia undergoing testicular
sperm extraction for a total of 46 IVF-ICSI cycles (12 fresh, 34
frozen). No statistically significant differences were noted
between the fresh and frozen-thawed testicular spermato-
zoa (20).
Cohen et al. 1997 (2) described a method where
cryopreservation and recovery of spermatozoa can be
performed even in patients who have fewer than 100
spermatozoa present in the final testicular tissue homo-
genate. A porous capsule, such as an emptied zona
pellucida, is used as a vessel to contain individual
spermatozoa. Empty zona pellucida is prepared by micro-
scopic dissection; specifically, small incisions are made in
the zona using a microsuction device. The emptied zona
pellucida is then maintained in Hepes-buffered media
supplemented with protein. A sperm suspension in 10%
PVP is then injected into the zona, placed in an 8% glycerol
solution and cryopreserved using a standard freeze protocol
with plastic straws. The use of an empty zona pellucida is
very advantageous for samples with very low numbers of
spermatozoa and also reduces the loss of motility associated
with post-thaw dilution and sperm washing, which is
observed when thawing frozen donor sperm (2).
In cases where freezing intact testicular tissue is required,
a method adapted from Allan and Cotman (1997) is used
(21). Testicular tubules are rinsed in HEPES-buffered
medium to eliminate or reduce red blood cell contamina-
tion. The tubules are sectioned with a scalpel blade into
pieces of approximately 2-3 mm and placed into a 35-mm
dish that contains HEPES-buffered medium and cryopro-
tectant medium at a 1:1 v/v ratio at room temperature.
Then, after 30 minutes, the samples are loaded into as many
cryostraws as required. The 30-minute room-temperature
equilibration period is ongoing during the loading process.
The straws are sealed and labeled with the patient’s name.
At the end of the 30-minute room-temperature equilibration
period, the straws are loaded into the goblets and cryocanes
and placed horizontally in the freezer for 30 minutes. At the
end of the 30-minute cooling period, the specimens are
hung over liquid nitrogen, well below the frost line of the
tank, for 30 minutes. Then, the specimens are plunged into
liquid nitrogen for continued storage. It is recommended to
cryopreserve a test straw and then thaw it to determine the
success of the cryopreservation procedure. To thaw these
samples, the straws must be taken out of the liquid nitrogen
tank and placed in a room-temperature water bath for 10
minutes. The contents are then expelled into room-
temperature HEPES-buffered medium, rinsed with fresh
HEPES-buffered medium and allowed to stand for 10
minutes before the sample is processed. The tissue is placed
in a sterile Petri dish with a small volume of HEPES-
buffered medium, sufficient to cover the tissue, and this
sample is then homogenized with fine needles. Using a
pulled pipette, a small volume of the homogenate is moved
to the ICSI dish, and motile sperm are captured using an
assisted hatching pipette. These sperm are then placed in a
drop of PVP. Note that overnight incubation of the
cryopreserved, thawed, and processed homogenate may
increase the effective yield of the preparation (22).
& FUTURE DIRECTIONS
Further studies and data will help to identify and define
how to more effectively extract sperm from men with
obstructive and non-obstructive azoospermia. A key issue
identified by Silber et al. (2003) is that there is a high
incidence of mosaicism in embryos derived from TESE.
Sperm retrieved from men with non-obstructive azoosper-
mia may have a higher rate of compromised or immature
centrosome structures, which may lead to mosaicism of the
embryo. Their results showed a significant difference in
mosaicism rates between embryos from ICSI cycles using
ejaculated sperm and embryos from ICSI cycles using TESE
for non-obstructive azoospermia (23).
Another key issue is the increased DNA fragmentation
observed in testicular sperm samples from patients with
azoospermia, due either to spermatogenic failure or duct
obstruction. Several studies have shown that male fertility
can be affected by DNA damage found in sperm (24,25). One
study yielded two interesting conclusions resulting from the
measurement of DNA fragmentation using the sperm
chromatin dispersion (SCD) test (25). The first conclusion
was that patients exhibiting low implantation rates and low
embryo quality may benefit from this test, which determines
the levels of DNA fragmentation. Second, the observation of
nucleolus asynchrony in a zygote from a sperm sample with
a high DNA fragmentation rate could indicate the possibility
of an upcoming low-quality blastocyst cohort (25). In
addition, sperm DNA fragmentation appears to be related
to the ability of sperm to fertilize the oocyte (25,26). The use of
fragmented sperm is still a matter of concern because of the
long-term consequences on the development and behavior of
the offspring. Still, studies have shown that oocytes may
partially repair fragmented DNA, depending on the level of
DNA fragmentation, producing blastocysts that are able to
implant and produce live offspring (23).
In addition, it has been shown that testicular cultures
should not be cultured for more than 48 hours to increase
motility. Aged spermatozoa may be more susceptible to the
damaging effects of free oxygen radicals. Moreover, an
increase in structural chromosomal abnormalities in in
vitro-stored spermatozoa has been reported (27).
The efficacy and safety associated with the retrieval of
incompletely developed spermatozoa (i.e., spermatids) from
men with non-obstructive azoospermia will also need to be
clarified over time. Anecdotal pregnancies and deliveries
from these clinical scenarios have been reported (28).
However, spermatids usually cannot be extracted from the
testis if TESE does not yield fully developed spermatozoa.
However, other new therapies, including spermatogonial
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transplants, have been reported in animal models. Because
many men with non-obstructive azoospermia may have
significant genetic abnormalities, caution must be exercised
before these fertility treatments can be accepted as standard
therapies (28).
In conclusion, the use of ICSI combined with sperm-
harvesting techniques has transformed fertility treatment
for azoospermic males. In both obstructive and non-
obstructive azoospermia, the sperm retrieval technique
itself seems to have no impact on the success rates of ICSI.
Laboratory techniques that recover sperm from surgical
specimens should be carried out with great care and
caution. It is important to not jeopardize the potential of
the sperm to fertilize the oocyte. The chances of retrieving
and recovering spermatozoa and of achieving a live birth by
ICSI are increased in couples in which the male partner has
obstructive rather than non-obstructive azoospermia (5).
Each laboratory technique described in this paper has
advantages and disadvantages; the embryologist must
determine which method yields the best chance of extract-
ing viable sperm for ICSI and enabling cryopreservation of a
patient’s sperm for future IVF cycles.
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